Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma

NCT00057980 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: celecoxib
DRUG: epirubicin hydrochloride

Sponsor

Northwestern University

Collaborators

[object Object]